14 December 2020 07:00 CET

EQT IX, through Roar BidCo AB, announces a public offer of SEK 220 in cash per share to the shareholders of Recipharm AB (publ) and SEK 1,427,010 in cash per Convertible Bond

#EQT IX #Recipharm

For more information, click here.

Latest news

01 December 2022
EQT partners with Nobel Prize Outreach to inspire and engage global audiences on societal challenges
28 November 2022
EQT Infrastructure enters exclusive negotiations to acquire a majority stake in Trescal, a global leader in calibration laboratories
22 November 2022
EQT AB’s Nomination Committee for the Annual Shareholders’ Meeting 2023
22 November 2022
Karo Intressenter AB announces final outcome of the public cash offer to the shareholders in Karo Pharma Aktiebolag
09 November 2022
EQT Ventures III closes Europe's largest venture capital fund committed to early-stage tech startups